11:44 AM EST - Amorfix Life Sciences Ltd. : announced today that the Company will collaborate with QPS Holdings, LLC, a leading global provider of discovery and development services for pharmaceutical, biotechnology and medical device companies, to further develop and validate its proprietary Alzheimer's disease diagnostic EP-AD assay. Amorfix Life Sciences Ltd.
shares T.AMF are trading down $0.01 at $0.35.
